Needham & Company LLC Reaffirms Buy Rating for Hims & Hers Health (NYSE:HIMS)
Hims & Hers Health (NYSE:HIMS – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a note issued to investors on Tuesday,Benzinga reports. They currently have a $61.00 price target on the stock. Needham & Company LLC’s price target suggests a potential upside of 17.14% from the stock’s previous […]
Hims & Hers Health (NYSE:HIMS – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a note issued to investors on Tuesday,Benzinga reports. They currently have a $61.00 price target on the stock. Needham & Company LLC’s price target suggests a potential upside of 17.14% from the stock’s previous […]
